First Trust Nasdaq Pharmaceuticals ETF (FTXH)

Assets	$34.54M
Expense Ratio	0.60%
PE Ratio	18.22
Shares Out	950,002
Dividend (ttm)	$0.42
Dividend Yield	1.24%
Ex-Dividend Date	Mar 26, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	1,467
Open	34.49
Previous Close	34.59
Day's Range	33.95 - 34.49
52-Week Low	24.25
52-Week High	35.61
Beta	0.47
Holdings	51
Inception Date	Sep 20, 2016

About FTXH

Fund Home Page

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: FTXH
• ETF Provider: First Trust
• Index Tracked: Nasdaq US Smart Pharmaceuticals Index

Top 10 Holdings

53.07% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	7.18%
Merck & Co., Inc.	MRK	6.98%
Bristol-Myers Squibb Company	BMY	6.97%
Johnson & Johnson	JNJ	6.93%
AbbVie Inc.	ABBV	6.78%
Viatris Inc.	VTRS	3.97%
Biogen Inc.	BIIB	3.76%
Pfizer Inc.	PFE	3.65%
Regeneron Pharmaceuticals, Inc.	REGN	3.43%
Gilead Sciences, Inc.	GILD	3.42%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 26, 2026	$0.0573	Mar 31, 2026
Dec 12, 2025	$0.1294	Dec 31, 2025
Sep 25, 2025	$0.1453	Sep 30, 2025
Jun 26, 2025	$0.0892	Jun 30, 2025
Mar 27, 2025	$0.0992	Mar 31, 2025
Dec 13, 2024	$0.1304	Dec 31, 2024

Performance

FTXH had a total return of 37.31% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.98%.